16 May 2023
Children Webinar | Neonatal Clinical Pharmacology—Held on 5 May 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
On Friday, 5 May 2023, MDPI and the journal Children (ISSN: 2227-9067) organized a webinar titled “Neonatal Clinical Pharmacology”. The webinar focused on the pharmacotherapy of newborns.
Prof. Dr. Karel Allegaert first introduced the limited size and extensive variability of neonatal clinical pharmacology. Dr. Robert B. Flint and Dr. Nadir Yalcin showed us new emerging tools that may facilitate the improvement of pharmacotherapy, for both pharmacokinetics (model-informed precision dosing) and -dynamics (machine learning to improve drug–drug interaction or adverse drug reaction recognition), and both approaches are subsequently discussed in the webinar to show ways and approaches for future progress.
Please note that this webinar is associated with a Special Issue in Children entitled “Neonatal Clinical Pharmacology”. The deadline is 25 August 2023.
You can watch the recorded webinar at the following link:
Webinar Chair and Keynote Speakers: